Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Fawaz Alkasim"'
Autor:
Akram J Jawad, Yassen F Alalayet, Fawaz Alkasim, Saad Alhamidi, Mohammad J Shoura, Eatedal Fathy Ghareeb, Bashar S Najjar
Publikováno v:
Journal of Applied Hematology, Vol 5, Iss 1, Pp 15-18 (2014)
Background and Objective: Recently totally implanted vascular access devices (TIVADs) have played an essential role in the management of pediatric patients. The purpose of this study was to describe the indications, techniques and complications of th
Externí odkaz:
https://doaj.org/article/afcdbc104af147d29512036a1ea07e5d
Publikováno v:
Saudi Medical Journal, Vol 41, Iss 1, Pp 46-52 (2020)
Saudi Medical Journal
Saudi Medical Journal
Objectives: To measure the incidence of vaso-occlusive crises (VOC) and the role of hydroxyurea (HU) in reducing VOC in sickle cell anemia patients being treated at a large tertiary care setting in Kingdom of Saudi Arabia (KSA). The secondary objecti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8a4fcf6bbae95cccc86ce1a5acc331e
https://www.smj.org.sa/index.php/smj/article/view/smj.2020.1.24698/11849
https://www.smj.org.sa/index.php/smj/article/view/smj.2020.1.24698/11849
Autor:
Tarek, Owaidah, Abdulakareem, Almomen, Ahmed, Tarawah, Ashraf, Warsi, Fawaz, Alkasim, Hazzaa, Alzahrani, Mahassen, Saleh, Ohoud, Kashari, Wasil, Jastaniah
Publikováno v:
Am J Blood Res
Introduction: Emicizumab is a bispecific monoclonal antibody with the ability to bridge FIXa and FX, mimic FVIII, and restore normal hemostasis in patients with hemophilia A. Moreover, substantial evidence has shown that emicizumab-treated patients d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::67c12a3b081b79f1a3b66599d05d6e99
https://pubmed.ncbi.nlm.nih.gov/35873100
https://pubmed.ncbi.nlm.nih.gov/35873100
Autor:
Yousef Qari, Satish Keshav, Aamer Aleem, Ahmad Jazzar, Mohamad H. Qari, Abdulrahman M Aljebreen, Faisal Batwa, Mazen S Taha, Srdjan Denic, Ali Al-Muhaini, Tarek Owaidah, Ahmad Alfadhli, Fawaz Alkasim, Abdulrahman Alfadda, Faisal Alsayegh, Hazzaa Alzahrani
Publikováno v:
Med Princ Pract
Background: Iron deficiency (ID) and ID anemia (IDA) are common in the member states of the Gulf Cooperation Council (GCC). The unique genetic and lifestyle factors of the patient population in the region have necessitated the development of recommen
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::809d0853761ef62721ead9dc5ad55779
https://doi.org/10.1159/000503707
https://doi.org/10.1159/000503707
Autor:
Abdullah Al-Jefri, Shaker Abdullah, Mohammed F. Essa, Faisal Al-Anzi, Nawaf Alkhayat, Wasil Jastaniah, Mouhab Ayas, Qasim Alharbi, Abdulrahman Alsultan, Fawwaz Yassin, Musa Alharbi, Fawaz Alkasim
Publikováno v:
Pediatric Blood & Cancer. 67
Background The frequency of pathogenic/likely pathogenic (P/LP) germline mutations in cancer-related genes among children with cancer in highly consanguineous populations is not well studied. Methods Whole-exome sequencing of germline DNA was perform
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::972db7a165a2f0ba623d954de3fda76e
https://doi.org/10.1002/pbc.28340
https://doi.org/10.1002/pbc.28340
Autor:
Faisal Al-Anzi, Nawaf Alkhayat, Fawaz Alkasim, Abdullah Al-Jefri, Mohammed Burhan Abrar, Abdulrahman Alsultan, Qasim Alharbi, Fawwaz Yassin, Shaker Abdullah, Mouhab Ayas, Musa Alharbi, Wasil Jastaniah
Publikováno v:
Cancer Epidemiology. 55:88-95
Background & aim Hereditary cancer susceptibility syndromes (HCSS) are reported in up to one-third of children with cancer. Diagnosis of HCSS is crucial for implementation of surveillance protocols. We identified children who fulfilled criteria for H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5115611323c657f4b486dbf83237a0d3
https://doi.org/10.1016/j.canep.2018.05.006
https://doi.org/10.1016/j.canep.2018.05.006
Autor:
Fawaz Alkasim, Abderrahim Khelif, Abdulhakim Al Rawas, Yasmin Goga, Rachida Boukari, Mohamed El Khorassani, Meriem Bensadok, Claude Negrier, Naglaa Mohamad Shaheen
Publikováno v:
Haemophilia. 25
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c8e609cc3e305cff649d2c80f841fa45
https://doi.org/10.1111/hae.13726
https://doi.org/10.1111/hae.13726
Autor:
Saad Alhamidi, Yassen F Alalayet, Bashar S Najjar, Eatedal Fathy Ghareeb, Fawaz Alkasim, Akram J Jawad, Mohammad J Shoura
Publikováno v:
Journal of Applied Hematology, Vol 5, Iss 1, Pp 15-18 (2014)
Background and Objective: Recently totally implanted vascular access devices (TIVADs) have played an essential role in the management of pediatric patients. The purpose of this study was to describe the indications, techniques and complications of th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0c38332e2426b63d88b5df8b8f8baef
http://www.jahjournal.org/article.asp?issn=1658-5127
http://www.jahjournal.org/article.asp?issn=1658-5127
Autor:
Ismail Beshlawi, S. AlSharidah, Fawaz Alkasim, S. Al‐Lamki, T. Al Lawati, W. Al Riyami, Y. Wali, K. Al Saadi, M. F. Khanani, Abdul Hakim Al-Rawas, S. Al Kindi, Mohamed Elshinawy, A. Tarawa, Hanan F. Nazir, T. Al Subhi
Publikováno v:
Haemophilia. 22
Introduction The optimum mode of delivery in a known carrier of a haemophilia A is still an issue of debate. Aim This study was conducted to report a multicentre experience in Gulf Cooperation Council (GCC) on the incidence of intracranial haemorrhag
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c311f88812995b34afe7eac9a0c1fa82
https://doi.org/10.1111/hae.12842
https://doi.org/10.1111/hae.12842
Autor:
Mahmoud Abu-Riash, Tarek Owaidah, Ali Al-Omari, Hazzaa Alzahrani, Abdulkareem Al Momen, Mahasen Saleh, Fahad Alothman, Fawaz Alkasim, Abdulrahman Al-Musa, Said Y Mohamed, Khawar Siddiqui, Randa Al Nouno, Mansor Ahmed, Ahmed Tarawah, Fatima Al Batniji, Saud Abu-Herbish
Publikováno v:
Medicine. 96:e5456
Hemophilia A and B are X-linked diseases that predominantly affect male patients. Patients can develop coagulation factor inhibitors, which exponentially increases the treatment cost. However, the prevalence of factor VIII and IX inhibitors in Saudi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cbb0f6860e40275bc90a5e97ab205fce
https://doi.org/10.1097/md.0000000000005456
https://doi.org/10.1097/md.0000000000005456